GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 62 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $364,277 | +62.4% | 211,789 | +84.2% | 0.00% | +100.0% |
| Q2 2023 | $224,248 | +250.4% | 114,999 | +644.9% | 0.00% | – |
| Q1 2022 | $64,000 | -54.6% | 15,439 | +40.5% | 0.00% | -100.0% |
| Q4 2021 | $141,000 | -86.0% | 10,987 | -88.2% | 0.00% | -80.0% |
| Q3 2021 | $1,007,000 | -11.8% | 93,202 | -25.5% | 0.01% | -16.7% |
| Q2 2021 | $1,142,000 | +1042.0% | 125,084 | +1082.3% | 0.01% | +500.0% |
| Q1 2021 | $100,000 | +1566.7% | 10,580 | +624.2% | 0.00% | – |
| Q4 2020 | $6,000 | +500.0% | 1,461 | +303.6% | 0.00% | – |
| Q3 2020 | $1,000 | -85.7% | 362 | -42.4% | 0.00% | – |
| Q2 2019 | $7,000 | – | 628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |